Congratulations to the Harvard investigators and teams that have recieved NIH funding for the following trials units and networks:
Read about the NIH structuring of Clinical Trials Networks:
https://www.nih.gov/news-events/news-releases/nih-announces-restructured-hiv-clinical-trials-networks
See a map of all NIH funded CTUs and sites:
In November 2020, NIAID awarded grants to 35 U.S. and international institutions selected as HIV/AIDS CTUs. View information about these awards, listed alphabetically by institution, in the table below:
2 UM1 AI069412-15 : Boston/Jackson/Providence HIV Clinical Trials Unit (BJP HIV CTU) : Daniel R. Kuritzkes, Lindsey R. Baden, Kenneth H. Mayer Brigham and Women's Hospital
2 UM1 AI069456-15 : Botswana-Harvard T.H. Chan School of Public Health AIDS Initiative Partnership CTU : Shahin Lockman, Joseph M. Makhema Harvard School of Public Health
HIV Vaccine Trials Network (HVTN)
LOC: Lawrence Corey, Dan H. Barouch, Glenda E. Gray, Georgia D. Tomaras; Fred Hutchinson Cancer Research Center, Seattle; 2 UM1 AI068614-15
LC: Margaret J. McElrath; Fred Hutchinson Cancer Research Center, Seattle; 2 UM1 AI068618-15
SDMC: Peter B. Gilbert, Yunda Huang, Holly Janes; Fred Hutchinson Cancer Research Center, Seattle; 2 UM1 AI068635-15
AIDS Clinical Trials Group (ACTG)
LOC: Judith S. Currier, Joseph J. Eron; University of California Los Angeles; 2 UM1 AI068636-15
LC: Grace M. Aldrovandi; University of California Los Angeles; 2 UM1 AI106701-08
SDMC: Michael D. Hughes, Marlene Cooper; Harvard School of Public Health, Boston; 2 UM1 AI068634-15
International Maternal Pediatric Adolescent AIDS Clinical Trials Network (IMPAACT)
LOC: Sharon A. Nachman; Johns Hopkins University, Baltimore; 2 UM1 AI068632-15
LC: Grace M. Aldrovandi; University of California Los Angeles; 2 UM1 AI106716-09
SDMC: David E. Shapiro, Marlene Cooper; Harvard School of Public Health, Boston; 2 UM1 AI068616-15